ARTICLE | Clinical News
Antisense Therapeutics, Isis Pharmaceuticals preclinical data
July 1, 2013 7:00 AM UTC
In mice, ATL1103 for 3 weeks suppressed growth hormone receptor RNA expression and significantly reduced downstream insulin-like growth factor-1 ( IGF-1) RNA expression in the liver vs. Somavert peg...